FDA-Approved Antidepressants for a 14-Year-Old with Depression
For a 14-year-old with depression, fluoxetine and escitalopram are the only two FDA-approved medication options available. Fluoxetine is approved for ages 8 and older, while escitalopram is approved specifically for adolescents aged 12-17 years 1, 2.
Specific FDA Approvals
The FDA approval status is clear and limited:
- Fluoxetine (Prozac): Approved for major depressive disorder in children/adolescents aged 8 years or older 2
- Escitalopram (Lexapro): Approved for major depressive disorder in adolescents aged 12-17 years 1
These are the only antidepressants with FDA approval for pediatric depression 3. All other antidepressants used in this age group are prescribed off-label 3.
Critical Safety Considerations
All antidepressants carry an FDA black box warning for treatment-emergent suicidality in adolescents and young adults 2. The FDA mandates that patients of all ages starting antidepressant therapy be "monitored appropriately and observed closely for clinical worsening, suicidality, or unusual changes in behavior" 1.
Monitoring Requirements
The FDA specifically requires close observation "especially during the initial few months of a course of drug therapy, or at times of dose changes, either increases or decreases" 4. Expert consensus recommends:
- Initial assessment within 1 week of starting medication 4
- At each contact, assess: (1) ongoing depressive symptoms, (2) suicide risk, (3) adverse effects, (4) treatment adherence, and (5) environmental stressors 4
- The risk/benefit ratio favors SSRI use at approximately 11:1 (number needed to treat = 10; number needed to harm for suicidality = 112) 5
Treatment Approach
Combination therapy with psychotherapy (particularly cognitive behavioral therapy) plus an SSRI produces superior outcomes compared to either treatment alone 1, 6. This is not optional—psychotherapy should be strongly encouraged in any patient for whom medication is prescribed 7.
Starting Doses for a 14-Year-Old
For fluoxetine: Start at 10 mg daily, with increments of 10-20 mg to an effective dose of 20 mg (maximum 60 mg) 4
For escitalopram: Start at 10 mg daily, with increments of 5 mg to an effective dose of 10 mg (maximum 20 mg) 4
Do not start at higher doses—this increases the risk of deliberate self-harm and suicide-related events 4.
Duration of Treatment
Continue medication for close to 1 year after remission to prevent relapse 4, 5. Evidence shows the greatest relapse risk occurs in the first 8-12 weeks after discontinuation 4. One study found significantly fewer relapses with 32 weeks of continuation therapy compared to placebo 4.
Common Pitfalls to Avoid
- Do not use paroxetine—it should not be used in patients under 18 due to elevated risk of suicidal thoughts and acts 3
- Do not use venlafaxine—data show increased rates of hostility, suicidal ideation, and self-harm compared to placebo 3
- Do not use tricyclic antidepressants—they lack efficacy in children and adolescents 3
- Avoid antidepressants in children under 12—they should not be used for depression in children aged 6-12 years in non-specialist settings 8
When to Modify Treatment
Reassess treatment response after 4-8 weeks 6. If symptoms worsen or fail to improve despite adequate treatment, or if the patient becomes a risk to themselves or others, consultation with or referral to a mental health subspecialist is warranted 6.
The evidence for antidepressant efficacy in adolescents shows only marginal benefit overall 9, 10, but for moderate to severe depression, the benefits outweigh risks when proper monitoring is in place 5, 7. The inherent risk of untreated adolescent depression—which is common, costly, and potentially lethal—is greater than the risk of appropriately monitored antidepressant treatment 7.